CVP · Oncology CVP is a chemotherapy regimen combining cyclophosphamide, vincristine, and prednisone to suppress cancer cell growth through multiple cytotoxic and immunosuppressive mechanisms.
Ixabepilone (Ixempra) · Oncology Ixabepilone stabilizes microtubules by binding to β-tubulin, preventing their depolymerization and disrupting cell division.
Phase 2 pipeline
BKM120 and Erlotinib · Oncology BKM120 is a PI3K inhibitor, and Erlotinib is a tyrosine kinase inhibitor targeting EGFR.
BMS-986489 · Inflammation BMS-986489 is an anti-inflammatory agent.